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Abstract 
 
   As cancer related mortality decreases, the number of patients living with cancer 
symptoms and the side effects of cancer treatment will continue to grow. In 2016, over 1.5 
million Americans were newly diagnosed with cancer (American Cancer Society, 2016). Several 
major medical organizations including the American Society of Clinical Oncology (ASCO), the 
National Comprehensive Cancer Network (NCCN), and the World Health Organization (WHO) 
endorse the integration of palliative care into cancer care (Ramchandran, 2015). Although many 
cancer centers report offering palliative care, this remains largely limited to inpatient services. 
The stakeholders of the hospice and palliative care division of a large Midwest healthcare 
system have identified that there are many cancer patients who may benefit from palliative care, 
but fail to receive these services. This is substantiated by a low number of oncology palliative 
care referrals, a large portion of inpatient palliative care referrals occurring when patients are 
critically ill, low median length of hospice enrollment among oncology patients, and a low rate 
of oncology patients completing advance care planning prior to a hospice referral. The 
development of an evidence-based toolkit to improve oncology referrals to palliative care could 
improve timely and appropriate oncology referrals to palliative care. The Theory of Symptom 
Management and the PARIHS framework were used to develop a toolkit to increase timely and 
appropriate referrals to palliative care in this Midwest healthcare system. The toolkit includes a 
cost savings analysis, referral recommendations based on analysis of current oncology quality 
measure performance, marketing and educational materials for referring providers, an 
implementation protocol, and a sustainability plan. 
Keywords: “Oncology”, “palliative care”, “referrals”, “integration”, “collaboration”, “end 
of life”  
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Evidence Based Toolkit to Improve Oncology Referrals to Palliative Care 
Executive Summary 
 
Background 
 
 According to recent studies, although the majority of patients reported a preference to die 
at home, 60% of deaths occurred in the hospital and the median hospice length of stay was a 
mere 17.4 days (Gomes et al., 2013; National Hospice and Palliative Care Organization, 2015). 
Furthermore, nearly a quarter of all Medicare spending incurred in beneficiaries’ last year of life 
(Riley & Lubitz, 2010). Palliative care is one proposed solution to improving end of life care 
(IOM, 2015). 
Purpose 
  The physical and psychosocial symptom burden of cancer is high and can have 
detrimental effects on patient and family quality of life (Greer et al., 2013). Consequently, 
several major medical organizations including the American Society of Clinical Oncology 
(ASCO), National Comprehensive Cancer Network (NCCN), and the World Health Organization 
(WHO) endorse the integration of palliative care into standard cancer care (Ramchandran, 2015). 
Unfortunately, although many organizations offer both oncology and palliative care services, 
many are not fully integrated. The purpose of this DNP project is to propose a solution to the 
current gap in care delivery. 
Significance 
 Currently, despite widespread recommendations for the early integration of palliative 
care into oncology care, patients are often referred to palliative care late in their disease course or 
even worse, not at all (Rauenzhan et al., 2017; Reville et al., 2013; Schenker et al., 2014). This 
represents a significant failure to provide evidence-based care to oncology patients as palliative 
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care improves advance care planning (Kavalieratos et al., 2016), increases use of hospice (Kerr 
et al., 2016; Lustbader et al., 2017), and lowers healthcare utilization (Lustbader et al., 2017).  
Current Practice 
 The hospice and palliative care division of a large Midwest healthcare system has 
identified a problem in patient access to palliative care services, specifically among oncology 
patients. This is substantiated in data from the hospice and palliative care clinic collected from 
December 2015 to September 2017, which demonstrated a low number of oncology palliative 
care referrals (34.7% of total referrals), a large portion of inpatient palliative care referrals 
occurring when patients are critically ill (18.9% in critical care and 12.9% in telemetry/step 
down), low median length of hospice enrollment (mean 63 days, median 10 days), and only 
31.2% of oncology patients completing advance care planning prior to a palliative care referral. 
New Evidence 
 Evidence for the creation of the toolkit was systematically reviewed. First, barriers to 
oncology referrals to palliative care were identified. Second, characteristics of successful 
strategies to improve timely referrals to palliative care were evaluated. These analyses are 
depicted in Appendix A. Finally; grey literature was reviewed for financial considerations. This 
review identified a key area of opportunity in upcoming reimbursement changes (Appendix B).  
Financial Considerations 
 Historically, oncology has been exempt from performance measures focused on hospital 
readmission rates (Boccuti & Casillas, 2017).  This will change with the implementation of The 
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which will introduce 
comprehensive Medicare reimbursement changes for healthcare services (CMS, 2017).   
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These reimbursement changes usher in an era of new oncology performance indicators that are 
quality, not volume focused.  High priority measures for oncology include: 
• Proportion of patients who have completed an advance directive 
• Proportion of patients admitted to hospice for less than three days 
• Proportion of patients admitted to intensive care in the last 30 days of life 
• Proportion of patients who died from cancer without being admitted to hospice 
• Proportion of patients who received chemotherapy within 14 days of death 
• Proportion of patients who died from cancer with more than one emergency department 
visit in the last 30 days of life (CMS, 2017). 
Intervention 
 Considering this identified opportunity, given the current reimbursement climate, an 
evidence-based toolkit was developed to improve oncology referrals to palliative care. The 
toolkit includes: 
• Cost savings analysis based on current high priority oncology quality measure 
performance 
• Referral guidelines  
• Marketing and educational tools for referring providers 
• Protocol for implementation of toolkit 
• Sustainability plan 
Cost Analysis  
 Cost considerations for completion of the project include staff member time, DNP 
student time (which is without cost to the organization) and costs of resources provided. The 
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proposed project will result in a net gain of labor and resources for the organization. Appendix K 
provides a detailed description of the project budget.  
Recommendation 
 After the organizational assessment and literature review were complete, a 
recommendation was made to create an evidence-based toolkit to improve timely and 
appropriate referrals from oncology to palliative care. The toolkit was presented and accepted by 
stakeholders within the hospice and palliative care division. 
Results 
 Quality Measure Performance and Cost Savings Analysis. Current oncology quality 
measure performance was assessed using a retrospective chart review. The results were used to 
calculate current performance and resultant points under MACRA reimbursement criteria. A 
potential Merit-based Incentive Payment System (MIPS) report card was produced. The lowest 
performing quality measure was advance directive completion with 61.88% (N=160) of patients 
assessed as not having an advance directive documented in their medical chart (Appendix N). 
 If current performance continues, the highest possible score if all points are awarded for 
the remaining categories of improvement activities and advancing care information is 84.94%, 
which will result in a 4% positive payment adjustment in 2019. However, if not all points are 
awarded for the remaining two categories, the organization could receive no positive payment 
adjustment or a negative payment adjustment if the total points awarded is less than 25 or no 
data is reported. This analysis is depicted in Appendix O.  
 Referral Recommendations. The analysis did not determine the patient diagnosis, extent 
of metastasis, or functional status to be independently associated with quality measure 
performance. However, patients in the deceased group were more likely to have advanced 
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disease and a lower functional status and for that reason, these populations in particular should 
be considered for referral. Furthermore, this analysis supports that there were patients who 
performed well in terms of functional status and metastasis and still performed poorly in quality 
measure performance and vice versa. This supports current recommendations as set forth by the 
National Academy of Medicine (IOM, 2015) that palliative care is offered to all patients with 
serious illnesses.  Final recommendations for referring providers are a combination of current 
National Academy of Medicine recommendations and the results of the data analysis and are 
summarized in Appendix Q. 
 Substantiated Value of Palliative Care. One result of this analysis was the 
demonstrated benefit of palliative care on quality measure performance. For all analyses, a p 
value of <.05 was considered significant. Among deceased patients (n=45), palliative care was 
significantly associated with advance directive completion (60% vs 40%, p=.0189) and lower 
intensive care unit (ICU) utilization (100% vs 0%, p=.0435). There were only 5 patients who 
were admitted to the ICU in the 30 days preceding death and this small sample size does limit 
this significance. Nonetheless, the results are promising and support that palliative care can 
improve quality measure performance and ultimately reimbursement. This analysis is located in 
Appendix R. 
 Marketing and Educational Tools. Index cards were produced to succinctly 
communicate recommendations to referring providers. The de-identified version of the 
marketing material is located in Appendix U. Palliative care clinicians also received printouts of 
the data analysis with detailed explanations of results.  
 Implementation Protocol. A protocol for implementation of the toolkit was also 
presented and accepted by hospice and palliative care stakeholders. The implementation 
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protocol utilized the PARIHS framework for guidance. The theoretical outline of the 
implementation plan is located in Appendix S. Appendix T contains stepwise instructions for 
implementation.  The stepwise instructions refer to feedback forms for both palliative care 
clinicians and referring providers to evaluate the toolkit once it is implemented. These forms are 
located in Appendix V and Appendix W respectively. 
 Sustainability. The hospice and palliative care division has a plan for program growth, 
which includes hiring new physicians, nurse practitioners, and nursing staff as well as 
innovative ways to deliver care such as through telehealth and expansion of home based care 
services. In order for service lines to continue to develop, the division will need to continue to 
increase in patient referrals. Both referral data and quality measure performance should be 
monitored after implementation of the toolkit to measure success of the toolkit. Timelines for 
evaluation are included in the implementation protocol. Evaluation tools are located in 
Appendix X. 
Conclusion 
 As cancer mortality decreases the number of individuals living with cancer will continue 
to grow. Oncology patients stand to greatly benefit from the early integration of palliative care. 
Unfortunately, the stakeholders of a hospice and palliative care division of a large Midwest 
healthcare system have observed that oncology patients are being referred late in their disease 
course to palliative care services, or even worse not at all. A quality improvement project 
completed by a DNP student included the development of an evidence-based toolkit to improve 
timely and appropriate referrals from oncology to palliative care.  
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Introduction 
 Advances in healthcare have led to longer life expectancies for individuals with chronic 
and life limiting illnesses. Consequently, the field of palliative care is growing to meet the 
demands of this population (Kamal et al., 2016). Palliative care is the management of physical 
and psychosocial symptoms due to a serious or life limiting illness. The goal of palliative care is 
to improve patient and family quality of life (National Hospice and Palliative Care Organization, 
2017). Over the past 15 years, the field of palliative care has grown exponentially. Over 1700 
hospitals with more than 50 beds now offer a palliative care team and in more recent years 
palliative care has expanded into the community (Center to Advance Palliative Care [CAPC], 
n.d). 
 Although palliative care services are becoming more widespread, patient access to 
palliative care remains limited. The shortcomings in end of life care were addressed in the 2015 
National Academy of Medicine (formerly the Institute of Medicine [IOM]) report), Dying in 
America. The report recommended expanding palliative care programs (IOM, 2015). According 
to recent studies, although the majority of patients reported a preference to die at home, 60% of 
deaths occurred in the hospital and the median hospice length of stay was a mere 17.4 days 
(Gomes et al., 2013; National Hospice and Palliative Care Organization, 2015). The United 
States is home to the most expensive healthcare system in the world with a price tag that will 
account for 20% of the gross domestic product (GDP) by 2020 (Institute for Healthcare 
Improvement, 2017). Much of this is spent on end of life care with nearly a quarter of all 
Medicare spending incurred in beneficiaries’ last year of life (Riley & Lubitz, 2010). 
 Cancer patients may greatly benefit from palliative care. In 2016, over 1.5 million 
Americans were newly diagnosed with cancer (American Cancer Society, 2016). The physical 
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and psychosocial symptom burden of cancer is high and can have detrimental effects on patient 
and family quality of life (Greer et al., 2013). Consequently, several major medical organizations 
including the American Society of Clinical Oncology (ASCO), National Comprehensive Cancer 
Network (NCCN), and the World Health Organization (WHO) endorse the integration of 
palliative care into standard cancer care (Ramchandran, 2015). Although many cancer centers 
report offering palliative care, this remains largely limited to inpatient services. Furthermore, 
even fewer oncology clinics are fully integrated with palliative care (Hui et al, 2010).     
Problem Statement 
 Currently, despite widespread recommendations for the early integration of palliative 
care into oncology care, patients are often referred to palliative care late in their disease course or 
even worse, not at all (Rauenzhan et al., 2017; Reville et al., 2013; Schenker et al., 2014). This 
represents a significant failure to provide evidence-based care to oncology patients as palliative 
care improves advance care planning (Kavalieratos et al., 2016), increased use of hospice (Kerr 
et al., 2016; Lustbader., 2017), and lower healthcare utilization (Lustbader et al., 2017). In 
addition, the national hospice median length of stay remains low at 17.4 days and 60% of 
patients are dying in acute care settings although the majority preferred to die at home (Gomes et 
al., 2013; National Hospice and Palliative Care Organization, 2015). Thus, the cost of care at the 
end of life remains high while the quality of care provided is low. 
The stakeholders of the hospice and palliative care division of a large non-profit Midwest 
health care system have identified a similar problem with the quality of care provided to 
oncology patients within the organization. Patient access to palliative care services, specifically 
among oncology patients is limited. This is substantiated by a low proportion of new referrals 
coming from oncology providers, a large portion of inpatient palliative care referrals occurring 
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when patients are critically ill, low median length of hospice enrollment among oncology 
patients, and a low rate of oncology patients completing advance care planning prior to a hospice 
referral. Considering this, what is an evidence-based toolkit to improve timely and appropriate 
oncology referrals to palliative care that is feasible within this organization?  
Evidence Based Initiative 
 Evidence for the creation of the toolkit was systematically reviewed. First, barriers to 
oncology referrals to palliative care were identified. Second, characteristics of successful 
strategies to improve timely referrals to palliative care were evaluated. A search was conducted 
of the databases CINAHL and PubMed from September 20, 2017-September 27, 2017 for 
articles published between 2007 and 2017. Key words for the search were “oncology”, “cancer”, 
“palliative care”, and “referrals”. Studies selected for inclusion in the review were from peer 
reviewed academic journals, adult patients, English language, and in the United States. Articles 
that were not specifically about barriers or interventions to improve palliative care referrals to 
oncology were eliminated. An initial search included 213 results after removal of duplicates, of 
which 145 did not meet inclusion criteria, and 58 were excluded due to low statistical or 
methodological rigor or were position papers or practice guidelines. The remaining 10 articles’ 
reference lists were reviewed resulting in an addition of 3 more articles. A total of 13 articles 
were included in the review.  
 The studies included: one prospective cohort, one quasi experimental, multiple 
retrospective chart reviews, and multiple qualitative studies including surveys, focus groups, and 
structured interview. There could be several explanations for the level of evidence that is 
available. First, palliative care patients are patients with severe and life limiting illnesses which 
make them a population not amenable to rigorous randomized control trials that could jeopardize 
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receiving the best level of care. Second, the disparity of oncology and a palliative care referrals 
remains despite well-published research regarding the benefits of integrating palliative care into 
oncology care and recommendations for the utilization of palliative care services from several 
major medical organizations (Ramchandran, 2015). Thus, qualitative research regarding what the 
referring providers perceive as their reasons for not referring is necessary to understand the 
continued low referral rate. This disparity also represents a mismatch of evidence-based practice 
and current practice that may explain the high volume of quality improvement interventions as 
opposed to experimental research (American Academy of Family Physicians, n.d). Appendix A 
displays both barriers and facilitators identified in the literature. Finally, financial considerations 
for the integration of palliative care into oncology care were explored and are displayed in 
Appendix B. 
Barriers to Palliative Care Referrals 
 Access. Provider perceived burden on patients to spend more time at the clinic as well as 
financial and disease concerns limiting ability to attend palliative care appointments were 
commonly identified barriers in the literature (Rabow et al., 2016). Lack of oncology provider 
awareness about locally available services was also identified as a potential barrier (Schenker et 
al, 2014). Finally, long wait times for palliative care appointments were identified by oncologists 
as a reason for not referring patients to palliative care (Feld, Horn, & Phillips, 2016). This 
implies that having palliative care services physically close to an oncology clinic or even within 
an oncology clinic alone is not a sufficient intervention to increase patient referral to palliative 
care. Oncology provider awareness of available services is crucial as are timely appointments 
and options to limit patient travel such as community based palliative care (CBPC) and 
additional visiting clinic sites. 
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 Oncology Provider Knowledge. Results of several studies showed that oncology 
providers’ knowledge about palliative care to be inadequate (Schenker et al., 2014; Walbert, 
Glantz, & Pudvali, 2016; Feld, Horn, & Phillips, 2016). This included misconceptions about the 
difference between hospice and palliative care, the inability to combine palliative care with 
aggressive treatment, and the belief that palliative care could be adequately provided by 
oncologists. This knowledge discrepancy also extended to nurses (Autor, Storey, & Ziemba-
Davis, 2013). Oncology providers also expressed hesitancy in discussing a palliative care referral 
with patients and felt that the referral would not be well received by patients (Feld et al, 2016), 
that a referral may alarm patients and their families (Smith et al., 2012), and even that patients 
would equate a palliative care referral with death (Rabow et al., 2016). Thus, referring providers 
need to be well equipped to discuss palliative care referrals with their patients and to be well 
informed of the characteristics and features of palliative care. 
 Ease of Collaboration. Finally, the ease of which referrals are initiated as well as the 
quality of ongoing collaboration between palliative care and oncology providers may impede 
palliative care referrals. In a focus group of oncology clinicians, referrers felt that they needed to 
feel confident in the quality and capability of the palliative care providers as well as to have 
defined responsibilities and clear team communication (Le et al., 2014). In an analysis of 
organizational factors influencing palliative care utilization at an academic cancer center, an 
unwieldy referral process, lack of same day appointments, and inadequate communication 
between palliative care and oncology providers were all identified as potential barriers (Le et al., 
2014). This supports the need for a referral process that is user friendly, fits in to office 
workflow, establishes what services each specialty will provide, and sets clear expectations for 
communication between oncology and palliative care providers.  
TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE 
 
15 
Effective Strategies to Improve Referrals to Palliative Care 
 Patient Screening and Defined Referral Criteria. Two studies implemented the 
Edmonton Symptoms Assessment Scale (ESAS) to better identify patients who may benefit from 
a palliative care referral. Hui et al. (2017) collected data pre, during, and post implementation of 
the scale, which was administered by a medical assistant prior to appointments and reviewed by 
a provider during the appointment. There was an increase in palliative care referrals from 12% 
prior to the intervention to 28% after, however this was not deemed statistically significant. 
Rauenzhan et al. (2017) implemented the ESAS in five oncology clinics after a brief staff 
education session about the tool and the consultation ordering process. Referrals prior to the 
intervention were an average of one patient per month and increased to an average of 10.8 
patients per month.  
 Another study implemented eligibility criteria for automatic palliative care referrals to 
expedite referrals to palliative care among patients with cancer identified in the literature to be at 
high risk for uncontrolled symptoms, emotional distress, and prolonged hospitalization. Criteria 
included advanced cancer (stage IV solid tumor or stage III lung or pancreatic cancer), prior 
hospitalization within 30 days, hospitalization greater than 7 days, and active palliative 
complaints. The result was a statistically significant increase in palliative care consultations 
(39% to 80%) and hospice referrals (24% to 26%), as well as declines in 30- day readmission 
rates (35% to 18%) and chemotherapy after discharge (44% to 18%) (Adelson et al., 2017). This 
suggests that having established referral criteria may be a timely and easy to implement 
intervention to increase referrals.  
 Provider Education. As identified above, lack of provider knowledge about palliative 
care is a significant barrier to palliative care referrals. In a small but significant study of 
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attending oncologists, one nurse practitioner, fellows, and house staff, a didactic presentation, an 
education outreach visit, and pocket sized cards with referral criteria increased referrals from 
24.9% to 31.5% in the 7.5 months post intervention. Interestingly, prior to the intervention the 
majority of palliative care referrals were for end of life issues (44.1%), goals of care (37.3%), 
and pain management (34.9%). After the intervention this was reversed with more referrals for 
pain management (47.2%), goals of care (34.9%), and end of life issues (29.2%) (Reville, 
Reifsnyder, MgGuire, Kaiser, & Santana, 2013). These results support that enhancing provider 
knowledge about the services palliative care providers can provide as well as their competence to 
provide these services and providing defined referral criteria may be a useful intervention in 
increase oncology referrals to palliative care. 
 Branding. There are several studies that support that changing the name of palliative care 
to “supportive care” may increase both referring provider and patient acceptance. In a survey of 
17 oncologists at an academic cancer center, providers perceived that their patients were more 
receptive to being offered supportive care rather than palliative care although they did not feel 
that this would change their referral patterns (Rhondali, Burt, Wittenberg-Lyles, Bruera, & Dalal, 
2013). Walbert et al. (2016) conducted an anonymous survey of 239 physicians, nurse 
practitioners and physician assistants at an annual neuro-oncology meeting and found equivocal 
results with 51% preferring the name supportive care rather than palliative care. 
 In a retrospective chart review of 4710 consecutive oncology patients seen for first time 
palliative care consultations, consultations prior to a name change to supportive care were 
compared to those after the name change. After changing the name of the service from palliative 
to supportive care, 41% more palliative care consultations occurred, inpatient referrals increased 
from 733 to 1451, outpatient referrals occurred sooner from hospital discharge, and median time 
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from advance cancer diagnosis to palliative care consultation decreased 1.7 months (Dalal et al., 
2011). 
 Finally, in a randomized telephone survey of 169 patients with advance stage cancer, 
patients were randomized into four groups that differed by name (supportive care versus 
palliative care) and (patient-centered versus traditional). When compared to palliative care, the 
term supportive care was associated with better understanding, more favorable impressions, and 
higher future perceived need (Maciasz et al, 2013). Although there may be other environmental 
and organizational changes occurring during these interventions that may have influenced these 
results, this is promising evidence in support of including the term “supportive” care in the clinic 
name or department description. 
Financial Considerations 
 Several retrospective studies have demonstrated the relative cost savings of palliative 
care from a health system perspective. This is largely due to increased use of hospice (Kerr et al., 
2014; Lustbader et al., 2017), fewer hospitalizations (Greer et al., 2016; Khandelwal et al., 2016; 
Lustbader et al., 2017; Penrod et al., 2010) and lower direct costs accrued during hospitalizations 
(McCarthy et al., 2015; Penrod et al., 2010; Starks et al.,2013; Whitford, Nilay, & Moriart, 
2013).  Cost savings could be used to bolster the argument in support of early integration of 
palliative care. However, this may not be enough to motivate individual referring providers and 
has been presented before by this organization to referring oncology providers to no avail.  
 Historically, oncology has been exempt from performance measures focused on hospital 
readmission rates unlike other life-limiting illnesses such as heart failure and chronic obstructive 
pulmonary disease (Boccuti & Casillas, 2017). This will change with the implementation of The 
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which will introduce 
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comprehensive Medicare reimbursement changes for healthcare services (CMS, 2017). These 
reimbursement changes usher in an era of new oncology performance indicators that are more 
quality, not volume focused.  High priority measures for oncology include:  
• Proportion of patients with a completed Advance Directive  
• Proportion of patients admitted to hospice for less than three days 
• Proportion of patients admitted to intensive care in the last 30 days of life 
• Proportion of patients who died from cancer without being admitted to hospice 
• Proportion of patients who received chemotherapy within 14 days of death  
• Proportion of patients who died from cancer with more than one emergency department 
visit in the last 30 days of life (CMS, 2017).  
These changes may be powerful motivators for oncology providers as several of the high priority 
oncology quality measures are directly related to palliative care (Howie & Peppercorn, 2013). 
Summary of Evidence Based Initiative  
 The cause of the current disparity in oncology referrals to palliative care is multifactorial. 
The solution will need to address numerous barriers in order to effectively improve oncology 
referrals to palliative care. The most feasible strategy for this organization is the incorporation of 
defined referral criteria. This was determined based on oncology provider preferences as well as 
input from the stakeholders at the hospice and palliative care organization. This intervention was 
also demonstrated to be effective in multiple studies in the literature review. The solution also 
needs to demonstrate financial benefit to the organization as a whole. Thus, the clinical question 
that was addressed is: what is an evidence-based toolkit to improve timely and appropriate 
referrals from oncology to palliative care that is feasible within the identified Midwest healthcare 
system?  
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Conceptual Models 
 Conceptual models provide a lens through which to view and understand a phenomenon 
of interest. This is done through a network of concepts and their relationships (McEwen & Wills, 
2014). The development of an evidence-based toolkit to improve timely and appropriate 
oncology referrals to palliative care is the phenomenon of interest. The conceptual model that 
was used to better understand this population of patients and the symptoms that they experience 
is the Theory of Symptom Management. Similarly, a framework for implementation can guide 
the translation of evidence into practice. The Promoting Action on Research Implementation in 
Health Services (PARIHS) provided the framework for the development of an evidence-based 
toolkit to improve timely and appropriate oncology referrals to palliative care. 
Theory of Symptom Management 
 The Theory of Symptom Management is a middle range nursing theory developed by 
faculty at the University of California, San Francisco (UCSF) (UCSF School of Nursing 
Symptom Management Faculty Group, 1994). The theory was originally developed to guide 
nurses to manage distressing symptoms by eliminating the symptom or removing the distress of 
the symptom (Humphreys et al., 2014). The theory has three major interactive concepts: 
symptom experience, symptom management strategies, and symptom status outcomes (UCSF 
School of Nursing Symptom Management Faculty Group, 1994).  
 Concepts. Theoretical concepts are defined as “the components of a phenomenon 
necessary to understand the phenomenon” (McEwen, M., & Wills, E., 2014, pp.27). The 
concepts of the Theory of Symptom Management are displayed in Appendix C and include 
symptom experience, symptom strategies, and outcomes. 
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 Symptom experience. Symptom experience is how individuals perceive, evaluate, and 
respond to what they are feeling (UCSF School of Nursing Symptom Management Faculty 
Group, 1994). Putting this in the context of oncology patients who may benefit from palliative 
care, cancer patients suffer from a wide array of physical and psychosocial symptoms of their 
disease as well as side effects from their treatment (Greer et al., 2013). The goal of palliative care 
is to understand the symptoms that patients experience and create plans of care that specifically 
address these symptoms (National Hospice and Palliative Care Organization, 2017).  
 Symptom strategies. Next, symptom strategies are methods to minimize the symptom 
experience (UCSF School of Nursing Symptom Management Faculty Group, 1994). When 
applying this to oncology patients who may benefit from palliative care, palliative care providers 
are trained to treat the symptoms of individuals living with chronic or life limiting illnesses and 
are thus uniquely prepared to implement care plans to eliminate or minimize symptoms. These 
strategies can include both pharmacological and non-pharmacological interventions and are often 
a combination of both (National Institutes of Health [NIH], 2010).  
 Outcomes. Finally, outcomes refer to physical wellbeing, psychological wellbeing, and 
quality of life (UCSF School of Nursing Symptom Management Faculty Group, 1994). Palliative 
care comprehensively addresses all of these outcomes. Palliative care is associated with 
improved patient quality of life, patient and caregiver satisfaction, and increased advance care 
planning (Kavalieratos et al., 2016) as well as improved symptom burden (Shamieh et al., 2017). 
Outcomes particular to this project are quality measure performance.  
 Domains. An updated version of the UCSF Theory of Symptom Management further 
refined the three major concepts of the model by placing them within the context of three nursing 
domains: person, health and illness, and environment (Dodd et al., 2001). Personal aspects refer 
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to demographic factors such as age, gender, and race (Dodd et al., 2001). These factors were 
collected to assess whether patient demographic variables affect palliative care referral or quality 
measure performance. Environmental aspects refer to culture, beliefs, and the location 
individuals live or access care (Dodd et al., 2001). The organization has identified that the 
current visiting palliative care clinic at a metropolitan oncology office has left many patients 
without access to palliative care services and that this is further exacerbated by a low rate of 
oncology referrals to palliative care. Expanding palliative care services to include an additional 
visiting clinic site or offering CBPC services to oncology patients could help address this gap in 
care. However, an adequate referral base would need to be established. Finally, health and illness 
refers to the current state of individuals’ health bearing in mind current diagnosis and disease 
course (Humphreys et al., 2014). Palliative care clinicians treat patients holistically, all the while 
assessing their current overall health status the current course of their cancer. 
 The concepts of the Theory of Symptom Management will be used to address barriers to 
palliative care referral. Symptom strategies will be used to explain the conditions and symptoms 
that palliative care clinicians treat including referral recommendations and to explain the services 
included with palliative care to referring providers. Outcomes will be used to analyze the cost 
savings of palliative care particularly as they are related to the new MACRA reimbursement 
criteria. Finally, the domains provided further criteria to consider when creating the toolkit to 
improve oncology referrals to palliative care. The personal domain was used to identify at risk 
populations where current care discrepancies exist such as those outside the area of the current 
visiting clinic and those demographic groups who receive fewer palliative care referrals. The 
health and illness domain was used to explain the balance between the respective care of 
palliative and oncology providers. This helps set boundaries and expectations and identifies 
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barriers to effective oncology and palliative care collaboration. Finally, the environment domain 
was used to describe the setting for implementation of the toolkit such as the main hospital 
campus and regional sites.  
The PARIHS Framework 
 The Promoting Action on Research Implementation in Health Services (PARIHS) 
framework was designed to assist with the translation of evidence into practice (Kitson, Harvey, 
& McCormack, 1998). Because incorporating palliative care into standard oncology care is the 
best practice recommendation from numerous medical organizations, the PARIHS framework is 
appropriate to use to develop an evidence-based toolkit to improve timely and appropriate 
oncology referrals to palliative care (Ramchandran, 2015). The three major concepts of the 
PARIHS framework are evidence, context and facilitation (Appendix D). The concepts are 
directly related, so that the strongest environment for change occurs when evidence, context, and 
facilitation are strong and the weakest environment for change occurs when evidence, context, 
and facilitation are low (Kitson, Harvey, & McCormack, 1998). The concepts of the PARIHS 
framework were applied to the hospice and palliative care division of a large Midwest healthcare 
system in which the evidence-based toolkit was developed.  The framework was also used to 
develop an implementation protocol for the toolkit and will be discussed in the results section. 
The relationships in the framework are displayed in Appendix D.  
 Evidence. Evidence includes research, practitioner expertise and experience, 
community/intended population, and the local environment; all forms of evidence should be 
assessed and evaluated for strengths and weaknesses. There is a wealth of research evidence in 
support of the early integration of palliative care into standard oncology care. Palliative care is 
associated with improved patient quality of life, advance care planning, patient and caregiver 
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satisfaction, and lower healthcare utilization (Kavalieratos et al., 2016). Early palliative care may 
lengthen survival time in certain patient populations, particularly cancer patients (Temel et al., 
2010). Finally, palliative care has also been demonstrated to decrease healthcare costs (McCarthy 
et al., 2015; Penrod et al., 2010; Starks et al.,2013; Whitford, Nilay, & Moriart, 2013).   
The organization stakeholders have identified that there are many cancer patients who 
may benefit from palliative care, but fail to receive these services. Having cohesive and ardent 
clinical views among staff is consistent with having strong practitioner expertise and experience. 
Patient preference also generates evidence. Again, palliative care improves patient and caregiver 
satisfaction (Kavalieratos et al., 2016).  
Context. The context is the setting or environment in which a proposed intervention 
takes place (Kitson, Harvey, & McCormack, 1998). This includes the culture and leadership 
infrastructure of an organization. The Burke-Litwin (1992) model was used to conduct an 
organizational assessment of the identified Midwest healthcare system and included an 
assessment of culture and leadership.  
 The mission and values of the healthcare system influence the hospice and palliative care 
division culture. The mission of the healthcare system is to improve the health of the 
communities served and the system-wide vision is to be a national leader in healthcare. Both the 
mission and vision of the healthcare system along with the support of the organization suggest 
that creating an evidence-based toolkit to improve timely and appropriate oncology referrals to 
palliative care is highly relevant and important to the organization.  
The leadership within the organization is a vertical chain of command. The 
measurements the organization uses are reported frequently and include national benchmarks 
such as average length of stay on hospice and admissions to the hospice and palliative care 
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programs. Of significance, is that the organization is not currently tracking the new Centers for 
Medicare and Medicaid Services (CMS) high priority oncology measures. Baseline CMS 
measures related to oncology were gathered as part of the project and assessed to assist with the 
cost analysis proportion of the toolkit as well as to create sustainability of the movement to 
improve oncology referrals to palliative care. These findings are discussed in the results section. 
 Facilitation. Facilitation includes the internal support provided by an organization to 
promote and sustain change (Kitson, Harvey, McCormack, 1998). The organization is comprised 
of individuals who are passionate about the work that they do and about ensuring that patients 
have access to their services. The organization has repeatedly invested in quality improvement 
and expansion as evidenced by the new CBPC program. The organization is also part of the 
initial cohort of organizations implementing the Centers for Medicare and Medicaid Services 
Medicare Care Choices Model (MCCM), which started in 2016 (Centers for Medicare and 
Medicaid Services [CMS], 2017). Finally, the organization has hosted two prior Doctor of 
Nursing Practice (DNP) students to implement change at the organization. Thus, the buy in and 
the willingness to assist with change are high.  
The PARIHS framework (Kitosn, Harvey, & McCormack, 1998) was used to assist with 
the translation of evidence in to practice to create an evidence-based toolkit to improve timely 
and appropriate oncology referrals to palliative care within an identified organization. The 
evidence in the literature and clinician experience, context of the organization, and strong 
facilitation within the organization were utilized to successfully create and disseminate the 
toolkit to stakeholders within the organization. 
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Need and Feasibility Assessment of the Organization 
Assessment of Organizational Needs and Resources 
 The hospice and palliative care division of a large Midwest healthcare system has 
identified a problem in patient access to palliative care services, specifically among oncology 
patients. This is substantiated in data from the hospice and palliative care clinic collected from 
December 2015 to September 2017, which demonstrated a low number of oncology palliative 
care referrals (34.7% of total referrals), a large portion of inpatient palliative care referrals 
occurring when patients are critically ill (18.9% in critical care and 12.9% in telemetry/step 
down), low median length of hospice enrollment (mean 63 days, median 10 days), and only 
31.2% of oncology patients completing advance care planning prior to a palliative care referral. 
Implementing an evidence-based toolkit to improve oncology referrals to palliative care is one 
way to help bridge this gap in the current care delivery. 
An organizational assessment of the hospice and palliative care division and the 
encompassing healthcare system was completed using the Burke Litwin Model of Organizational 
Performance and Change (1992). The model provided a comprehensive assessment of the 
organization through the evaluation of 12 variables, which explore organization structure and 
feasibility. The variables are displayed in Appendix E (Burke & Litwin, 1992). As demonstrated 
by the multidirectional arrows shown in the diagram, relationships between the variables may 
occur through both positive and negative feedback and are interrelated. The variables located 
towards the top of the diagram have a stronger influence on change than those located near the 
bottom. The organizational assessment identified strong context and strong facilitation within the 
organization.  
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SWOT Analysis of Proposed Intervention 
 A SWOT analysis was conducted after the organizational assessment. A SWOT analysis 
is a tool used to evaluate the strengths, weaknesses, opportunities, and threats to a project 
(Zaccagnini & White, 2017). This helps to plan for and appropriate resources to weaknesses as 
well as to maximize strengths and areas for growth. The SWOT analysis for development of an 
evidence-based toolkit is displayed in Appendix F.  
 Strengths. The hospice and palliative care division stakeholders identified this problem 
as well as expressed interest and support in finding a solution. This represents support to 
complete the project. Secondly, the clinic is one of the largest palliative care programs in west 
Michigan and under the umbrella of one of the largest healthcare systems in the Midwest, both 
lending to financial and structural support. Finally, this organization has recently invested in 
expanding community palliative care services and offering the Medicare Care Choices program. 
This will provide some clinical infrastructure for growth that is already in place.  
 Weaknesses. The largest weakness was a reported history of reluctance among oncology 
providers to refer patients to palliative and hospice services. The existing confusion within the 
organization as well as the healthcare system about the differences between palliative care and 
hospice and the programs currently offered also weakens the referral base. Confusion about what 
palliative care entails was also identified as a barrier in the literature (Autor, Storey, & Ziemba-
Davis, 2013; Feld, Horn, &Phillips, 2016; Schenker et al. 2014). 
 Opportunities. Oncology has long been exempt from performance measures focused on 
hospital readmission rates unlike other life-limiting illnesses such as heart failure and chronic 
obstructive pulmonary disease (Boccuti & Casillas, 2017). The Medicare reimbursement changes 
that will follow the implementation of MACRA usher in an era of new oncology performance 
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indicators that are more quality, not volume focused. This represents an opportunity for the 
hospice and palliative care division to tactfully market their services as providing services 
targeted towards improving not only patient satisfaction but also, quality measures and 
ultimately reimbursement (Howie & Peppercorn, 2013).  
 Threats. The largest threat to the proposed project was the cost analysis not 
demonstrating significant value of palliative care services. There was also the potential for 
inadequate planning for program growth. Because of this, an implementation and sustainability 
plan were included in the toolkit.   
 Overall, the hospice and palliative care clinic stakeholders identified a gap in palliative 
care delivery to oncology patients within their organization and were ready and willing to 
participate in a solution to this problem. Strong evidence, context, and facilitating factors to 
support this initiative were identified through an integrative literature review, organizational 
assessment, and SWOT analysis.  
Project Plan 
Purpose of Project 
 The purpose of this DNP scholarly project was to develop a toolkit to improve timely and 
appropriate oncology referrals to palliative care. This was accomplished by answering the 
clinical question: What is an evidence-based toolkit to improve timely and appropriate oncology 
referrals to palliative care that is feasible within this organization? 
Objectives  
 An evidence-based toolkit to improve timely and appropriate oncology referrals to 
palliative care completed the following objectives: 
• Collect baseline data to establish the current state of oncology measures 
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• Perform a cost savings analysis of current high priority oncology quality measure 
performance utilizing MACRA reimbursement criteria to substantiate value by February 
22, 2018 
• Establish referral recommendations for oncology providers utilizing a regression analysis 
with the consultation of a Grand Valley State University graduate statistics student to 
determine which patient demographics and disease characteristics are associated with 
poor quality measures performance by February 22, 2018 
• Create protocol plan by February 23,2018 for implementation of toolkit which includes: 
o Cost savings analysis based on current quality measure performance 
o Referral recommendations for oncology clinicians 
o Marketing and educational tools for referring clinicians 
o Implementation protocol for palliative care clinicians 
o Sustainability plan for palliative care clinicians 
• Create marketing and educational tools for referring oncology clinicians and present this 
to organizational stakeholders on February 22, 2018 
• Create sustainability plan by February 22, 2018  
• Disseminate work to key stakeholders for acceptance for implementation on February 
22, 2018.  
Type of Project 
 The project was a quality improvement project. Quality improvement is defined as a 
“systematic, formal approach to practice performance and efforts to improve performance” 
(American Academy of Family Physicians [AAFP], n.d). Quality improvement involves analyzing 
organizational culture, identifying and prioritizing practice problems, collecting and analyzing 
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data, communicating results, and ongoing evaluation (AAFP, n.d). Organizational culture and the 
practice problem were identified through the organizational assessment and SWOT analysis. The 
data collected was current high priority oncology quality measures, which were analyzed for cost 
savings potential utilizing MACRA reimbursement criteria and underwent a logistic analysis, Chi-
Square, or Fisher’s exact test where appropriate to identify high-risk populations that should be 
considered for early referral to palliative care. Finally, the results of the analysis were incorporated 
into the toolkit that included an implementation and sustainability plan. The toolkit was 
disseminated to key organizational stakeholders.  
Setting and Needed Resources 
 The hospice and palliative care division of a large Midwest healthcare system was the 
setting for this DNP scholarly project. The resources for this project included access to electronic 
medical records to obtain patient data related to oncology quality measures as well as a laptop 
with access to a secure hard drive and an organizational e-mail address. Staff time commitment 
included time from quality improvement, administrative, and clinical staff to participate in 
meetings and project discussions. A team was established at Grand Valley State University to 
assist the DNP student in completing the project and included an organizational mentor 
(Department Chief of the hospice and palliative care program), a committee member with an 
expertise in in palliative medicine, a committee member that is a practicing palliative care 
APRN, and a committee chair with an expertise in the DNP scholarly project. An informal team 
was also established and included the manager of hospice and palliative care program 
development and a graduate GVSU statistics student. 
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Design for Evidence-Based Initiative 
 The PARIHS framework (Kitson, Harvey, & McCormack, 1998) was used to guide the 
development of an evidence-based toolkit to improve timely and appropriate oncology referrals 
to palliative care: 
• Evidence from a comprehensive literature review as well as clinician expertise guided 
the development of the toolkit. Evidence from grey literature, which is literature that is 
not published commercially and often includes reports, market research, and memoranda 
was also used to further investigate CMS reimbursement and quality measures 
(Grey.Lit.org, n.d). 
• Context also played a role. The current culture at the hospice and palliative care division 
is strong and supportive of change and growth. The purpose of the toolkit is to address a 
problem that clinicians have identified as a current gap in care.  
• Facilitation was also considered when developing an implementation and sustainability 
plan. This included a cost analysis, referral guidelines, as well as an implementation and 
sustainability plan including how and when to track quality measures and referral rates in 
the future. 
Participants 
 Participants for the project were the 418 patients whose charts were retrospectively 
reviewed and the stakeholders and palliative care staff members who were presented the toolkit 
for acceptance. The patient population are patients who were treated at one of the healthcare 
system’s cancer centers from September 1, 2016- September 1, 2017. The stakeholders who 
were presented the toolkit are the division chief, manager of program development, and at least 
one clinician of the hospice and palliative care clinic.  
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Measurement: Source of Data 
 Data collection to inform the toolkit was performed by the DNP student and 
administrative staff. The data collected was used as a baseline and to perform a cost analysis of 
what current reimbursement impact will be utilizing the new MACRA criteria. Data collected 
was also used to perform an analysis to determine which patient demographics, cancer 
diagnoses, and disease characteristics were associated with poor quality indicator performance 
to guide referral recommendations. The cancer diagnoses that were analyzed were selected by 
determining the cancers with the highest incidence in the U.S according to the National 
Institutes of Health (NIH, 2014) in conjunction with cancer diagnoses that have been shown to 
perform poorly for the quality measures being assessed. A literature review of cancers and 
quality measure performance is located in appendix H.  
 Functional status was also frequently assessed in the literature as a potential independent 
variable affecting quality measure performance. Due to the ease of use and demonstrated 
validity in the literature, the Eastern Cooperative Oncology Group (ECOG) performance status 
was used to assess functional status of the reviewed patients (Oken et al., 1982; Cleeland et al., 
2013). The ECOG tool is depicted in Appendix I. Whenever possible ECOG scores were taken 
directly from clinician documentation. If a score was not explicitly stated, the DNP student 
scored the patient based on their most recent office note physical assessment and self reported 
symptom assessment sheet. The final list of collected variables is located in Appendix J.   
 The DNP student was required to complete and sign an Acknowledgement of Training in 
Patient Privacy in Research training. The DNP student also completed electronic medical record 
(EMR) training and was granted access to the EMRs used within the hospice and palliative care 
division. These EMRs include EPIC and Cerner. Finally, the DNP student was granted access to 
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the network where all of the documents for the hospice and palliative care division are stored 
and shared. The data collected was for all patients treated at one of the healthcare system’s 
cancer centers from September 1,2016-September1, 2017. Patients treated for a non-oncology 
diagnosis were excluded. Sample size was calculated to be 160. A randomized selection was 
used and pulled from the 418 charts reviewed meeting inclusion criteria. Charts were reviewed 
to determine: 
• Age 
• Gender 
• Primary cancer diagnosis 
• Metastasis status 
• ECOG score (0-4) 
• Admission to palliative care services status 
• Advance Directive completion 
• Deceased status 
• Admission to hospice status  
• Hospice length of stay 
• Admission to intensive care in the last 30 days of life 
• Chemotherapy in the last 14 days of life 
• More than one emergency department visits in the last 30 days of life.   
Appendix G contains the spreadsheet for data collection. A number was assigned to patients 
to de-identify patient information. Data was stored on the organization’s network and 
password protected. 
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 Budget. A budget was created to demonstrate time needed from hospice and palliative 
cares team members to implement and sustain the toolkit as well as needed materials 
(Appendix K). 
 Cost Savings Analysis. The toolkit includes an assessment of current quality indicators 
and the reimbursement implications that will start in 2019 under MACRA. There is a 4% 
penalty or reward depending on quality measure performance. In addition, this cost 
adjustment will biannually increase until 2022 to a penalty or reward of 9% (CMS, 2017b). 
Steps for Toolkit Development 
The completion of this DNP scholarly project included (Appendix L): 
• Data collection retrospectively from patient charts utilizing EMRs to collect: Primary 
cancer diagnosis, age, gender, metastasis, ECOG score, deceased status, admission to 
hospice status, hospice length of stay, admission to palliative care services status, 
admission to intensive care in the last 30 days of life, receipt of chemotherapy within the 
last 14 days of life, and more than one visit to emergency department visit in the last 30 
days of life  
•  A cost savings analysis of current high priority oncology quality measure performance 
utilizing MACRA reimbursement criteria to substantiate value 
• Referral recommendations for oncology providers utilizing a logistic analysis, Chi-
Square, or Fisher’s exact test where appropriate with the consultation of a Grand Valley 
State University graduate statistics student demonstrating any patient demographics, 
disease characteristics, or functional status associated with worse quality measure 
performance  
• Protocol plan for implementation of toolkit which includes: 
TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE 
 
34 
o Cost savings analysis based on current quality measure performance 
o Referral recommendations for oncology clinicians 
o Marketing and educational tools for referring clinicians 
o Implementation protocol for palliative care clinicians 
o Sustainability plan for palliative care clinicians 
• Presentation of the toolkit to key stakeholders for acceptance for implementation  
• Upload the toolkit to a digital folder within the protect hospice and palliative care 
network drive  
• Defense of the final toolkit at Grand Valley State University  
• Upload the toolkit to ScholarWorks©. 
Project Evaluation Plan 
 The evidence-based toolkit to improve timely and appropriate oncology referrals to 
palliative care within a hospice and palliative care division of a large Midwest healthcare system 
was evaluated based on acceptance by key stakeholders within the organization. Stakeholders, 
which include the medical director, manager of business and program development, and an 
organizational nurse practitioner, accepted the toolkit, which was the final outcome of this DNP 
scholarly project.  
Ethics and Human Rights Protection 
 The health system’s Institutional Review Board (IRB) determination was obtained and 
concluded the project to be non-human research on 11/20/2017. Grand Valley State University 
accepted the healthcare system’s determination and ruled equivocally on 11/26/2017. All data 
was de-identified and kept on the health system’s internal drive and password protected. 
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Business Model 
 This DNP scholarly project is the formation of a toolkit to increase appropriate referrals 
to the organization. The time and work completed by the DNP student is without cost to the 
organization. However, the organization invested time spent by administrative staff and 
clinicians to attend meetings, project defense, and final defense as well as by providing a laptop 
for the student from September 2017-April 2018. This budget is demonstrated in Appendix K. 
Stakeholder Support 
 The key stakeholders within the hospice and palliative care division, which include the 
medical director, manager of business and program development, and an organizational nurse 
practitioner, identified a practice problem in oncology referrals to palliative care. They have 
accepted a toolkit to address this problem. A letter indicating the organization’s support is 
located in Appendix M.  
Project Outcomes 
Current Quality Measure Performance and Cost Savings Analysis 
 Current oncology quality measure performance was assessed using a retrospective chart 
review. Of the 418 charts reviewed, 160 were included in the total population group using 
randomization.  There were 45 deceased patients and all deceased patients were used to assess 
quality measures related to end of life. Advance directive completion is the only quality measure 
that can be applied to the total population. The remaining five quality measures are all directly 
related to end of life and only deceased patient data was utilized.  
 The results were used to calculate current performance and resultant points under 
MACRA reimbursement criteria. A potential Merit-based Incentive Payment System (MIPS) 
report card was produced. The lowest performing quality measure was advance directive 
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completion with 61.88% of patients assessed as not having an advance directive. This was 
followed by proportion not admitted to hospice and proportion admitted to hospice for less than 
three days, both at 33.33%. Proportion of patients with greater than one emergency room visit 
and proportion of patients admitted to ICU in the last 30 days of life followed at 11.11% each. 
The best performing quality measure was proportion of patients who received chemotherapy in 
the last 14 days of life with an occurrence rate of 8.89%. It is important to note that quality 
measure performances are awarded points based on each score’s percentile to in relation to other 
hospitals. Because these are new quality measures, these percentiles will not be established until 
after the first performance year (2019). The target for these measures is estimated based on 
similar quality measure percentiles, which have historically set stricter targets for measures 
associated with higher costs such as hospitalizations and emergency room visits.  This report 
card is located in Appendix N.  
 If current performance continues, the highest possible score if all points are awarded for 
the remaining categories of improvement activities and advancing care information is 84.94%, 
which will result in a 4% positive payment adjustment in 2019. However, if not all points are 
awarded for the remaining two categories, the organization could receive no positive payment 
adjustment or a negative payment adjustment if the total points awarded is less than 25 or no 
data is reported. The monetary analysis of these adjustments is based on average cost for one 
emergency department visit as quoted by the organization’s insurance company and the average 
cost of acute hospitalization per day in Michigan (Rappleye, 2015).  It is imperative that 
performance be improved while reimbursement adjustments are low, as 2019 cost adjustments 
will be $40.00 for emergency room visits and $85.20 per ICU day but will increase to $90.00 
per emergency room visit and $191.70 per ICU day in 2022.  If this trend continues, the current 
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performance of five ICU hospitalizations is currently a negative adjustment of $426.00 per day 
with an average length of stay of three days, ultimately accruing a $1,278.00 negative payment 
adjustment for 2019. In 2022, this same performance will result in a negative adjustment of 
$958.50 per day total for the five patients, reaching $2,875.50 based on the current average 
length of stay of three days. Similarly, the current emergency room visit performance of four 
visits will result in a total of $160.00 negative adjustment in 2019 and will increase to $360.00 
in 2022. This analysis is depicted in Appendix O.  
Referral Recommendations 
 There were not enough observations among deceased patients run a logistic regression. 
For categorical variables chi-square tests or Fisher’s exact test was used where appropriate. A 
two- sample t-test was used to assess the relationship between patient age and quality measure 
performance. All analyses considered a p value of less than .05 to be significant. There was no 
significant relationship between gender or age for any of the quality measures aside from 
females and hospice length of stay less than three days (p=0.022). There was no significant 
relationship between metastasis, primary disease, or functional status and quality measure 
performance. Thus, there is no easy way to predict which patients will ultimately perform poorly 
in the assessed quality measures. 
 The deceased patients were more likely to have metastasis than the total population 
(93.18% vs 41.25%) and more likely to have higher ECOG scores (51.11% ECOG 2 & 22.22% 
ECOG 3, vs 56.88% ECOG 0 & 31.88% ECOG 1). This indicates that deceased patients were 
more likely to have advanced disease and lower functional status. The ages between both groups 
were equivocal with a mean age of 68.09 for the deceased group and a mean age of 67.43 for the 
total group. Tables describing both groups are located in Appendix P. 
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 Based on this analysis, although metastasis and functional status were not independently 
associated with poor quality measure performance, both variables were more common in the 
deceased group and for that reason these populations should be considered for referral. 
Furthermore, this analysis supports that there were patients who performed well in terms of 
functional status and metastasis and still performed poorly in quality measure performance and 
vice versa. This supports current recommendations as set forth by the National Academy of 
Medicine (IOM, 2015) that palliative care is offered to all patients with serious illnesses.  Final 
recommendations for referring providers are a combination of current recommendations and this 
analysis and are summarized in Appendix Q.  
Substantiated Value of Palliative Care 
 One result of this analysis was the demonstrated benefit of palliative care on quality 
measure performance. Among deceased patients, palliative care was significantly associated 
with advance directive completion (60% vs 40%, p=.0189) and lower ICU utilization (100% vs 
0%, p=.0435). There were only 5 patients who were admitted to the ICU in the 30 days 
preceding death and this small sample size does limit this significance. Nonetheless, these 
results are promising and support that palliative care can improve both quality measure 
performance and ultimately reimbursement. This analysis is located in Appendix R.  
Marketing and Educational Tools for Referring Providers 
 Index cards were produced to succinctly communicate recommendations to referring 
providers. The de-identified version of the marketing materials is located in Appendix U. 
Palliative care clinicians also received printouts of the data analysis with detailed explanations 
of results. 
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Implementation Protocol 
 A protocol for implementation of the toolkit, which includes: cost savings analysis, 
referral recommendations, marketing and educational tools, implementation protocol, and 
sustainability plan was presented and accepted by hospice and palliative care stakeholders. The 
implementation protocol utilized the PARIHS framework for guidance. The theoretical outline 
of the protocol is located in Appendix S. Appendix T contains stepwise instructions for 
implementation.  The stepwise instructions refer to feedback forms for both palliative care 
clinicians and referring providers to evaluate the toolkit once it is implemented. These forms are 
located in Appendix V and Appendix W respectively.  
Sustainability 
 The hospice and palliative care division has a plan for program growth, which includes 
hiring new physicians, nurse practitioners, and nursing staff as well as innovative ways to 
deliver care such as through telehealth and expansion of home based care services. In order for 
service lines to continue to develop, the division will need to continue to increase in patient 
referrals. Oncology patients are a patient population that has been identified as not receiving 
palliative services or receiving services late in their disease course. The clinicians within the 
organization are dedicated to growing this population along with their program, thus supporting 
the sustainability of a toolkit to drive an increase in oncology patient referrals. 
 Both referral data and quality measure performance should be monitored after 
implementation of the toolkit to measure success of the toolkit. The next DNP student at the 
organization will perform monitoring of new oncology referrals and quality measure 
performance. Timelines for evaluation are included in the implementation protocol. The 
organizational nurse practitioner that assisted in the completion of this project has agreed to 
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continue her involvement in the implementation and sustainability of the toolkit. Evaluation 
tools are located in Appendix X.  
Implications for Practice 
 The stakeholders of the hospice and palliative care clinic have identified that there are 
many cancer patients who may benefit from palliative care, but fail to receive these services. 
The development of a toolkit to improve timely and appropriate oncology referrals to palliative 
care will improve patient access to palliative care. As a direct result of this DNP project the 
hospice and palliative care division is enacting a new “opt out” policy for oncology referrals to 
palliative care to replace the current “opt in” policy. This means that all patients regardless of 
primary cancer diagnosis, extent of metastasis, or functional status will receive a palliative care 
referral. This will also improve patient and family satisfaction, increased use and length of stay 
on hospice, and overall healthcare costs. Finally, as demonstrated by the data analysis, 
increasing patient access to palliative care will improve oncology quality measure performance 
and ultimately reimbursement for referring oncology providers.  
Strengths 
 A major strength of the toolkit is that it was developed in cooperation with members of a 
hospice and palliative care division that are supportive of using the toolkit and ensuring success 
of the toolkit. The analysis performed demonstrated the value of palliative care in improving the 
lowest performing quality measure, advance directive completion. This may be a substantial 
motivator for referring providers. In addition, quality measure performance and the cost analysis 
demonstrate opportunity for improvement to optimize reimbursement, which again may be used 
as motivation for referring providers. 
Weaknesses 
TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE 
 
41 
 The major outcome of this project was the development of an evidence-based toolkit to 
improve oncology referrals to palliative care. The major weakness of this project is that the 
toolkit will still need to be implemented. Doctor of Nursing Practice projects may take on a 
variety of forms and thus may not always include implementation of a practice change. Most 
importantly, the DNP project needs to be driven by the clinical question or issue, which this 
project was. This project is most accurately described as an exploratory DNP project as it 
assessed the practices of healthcare professionals (oncology providers) and ultimately the 
healthcare system to provide baseline data that will be used to drive practice improvement 
(Moran, Burson, & Conrad, 2017). 
 Although the student has taken great care to include all possible necessities in the toolkit, 
there is always the possibility that after implementation there may be the need to modify the 
toolkit. This will be the responsibility of the next DNP student and the organizational nurse 
practitioner that assisted in the completion of this project. Part of quality improvement work is 
constant reevaluation.  
Relation to Other Evidence/Healthcare Trends 
 Palliative care has been one of the fastest growing healthcare specialties in the United 
States. Palliative care has been proven to increase patient satisfaction, improve symptom 
management, decrease intensive care in end of life, and to lead to cost savings (Hughes & 
Smith, 2014). Much of the demonstrated cost savings of palliative care in the literature has been 
through avoidance of cost such as less intensive care. This project has demonstrated additional 
cost savings in the form of improved quality measure performance to capture optimal 
reimbursement for services.  
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 Barriers to the incorporation of palliative care into standard oncology care include 
physician resistance and unrealistic patient and caregiver expectations (Hughes & Smith, 2014). 
Through the development of the toolkit, the DNP student seeks to decrease physician resistance 
among referring providers by demonstrating tangible benefit to palliative care services as well as 
further define patients most likely to benefit. In a recently published proposed research agenda 
for high value palliative care, the question of how to best change clinician behavior around a 
palliative care referral was proposed (Courtright, Cassel, & Halpern, 2018). The implementation 
of this toolkit is one novel approach to answer this question. 
Limitations 
 This project had several limitations. First, the data analysis portion included a small 
deceased patient population (n=45). This rendered one of the significant relationships, the 
relationship of palliative care to ICU admission to be significant (p=.0435) but limited by a 
small cell count. Of the 20 patients that received palliative care services, 16 received services as 
inpatients and 4 received services as outpatients. Thus, there was not a large enough sample size 
to determine if earlier palliative care involvement through outpatient services significantly 
impacted outcome performance. There were two quality measures, admission to hospice and 
length of stay on hospice that approached but did not reach significance (p=.0897 & p=.0823). A 
potential future clinical question is: would significance have been reached with earlier palliative 
care involvement, as this has been demonstrated in the literature. Although these are current 
limitations, if referrals improve with implementation of the toolkit, there is a possibility that 
these questions could be answered more precisely with a larger sample size. Therefore, part of 
the sustainability plan includes monitoring quality measure performance. As the number of 
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oncology patient referrals grows, this analysis could be replicated to reevaluate this and further 
substantiate the value of palliative care on additional quality measure performance.  
Reflections on Doctor of Nursing Practice Essentials 
 The American Association of Colleges of Nursing (ACCN) has established eight 
essentials that define the curriculum of DNP programs. These essentials are the foundation upon 
which a DNP prepared nurse is prepared to practice (AACN, 2006) In completing this scholarly 
project the DNP student demonstrated all eight of the essentials. 
Scientific Underpinnings for Practice 
 Scientific underpinnings for practice refers to the underlying body of knowledge that 
governs nursing practice and includes an understanding of the health and illness continuum, the 
interaction of patients and environment, the nursing interventions that affect these relationships, 
and the theoretical foundations for practice (AACN, 2006). The DNP student assessed both 
patient and disease characteristics and the intervention of palliative care to determine how these 
independent variables affected oncology quality measures in order to inform referral guidelines. 
In addition, the project was to develop a new practice approach and was grounded in the Theory 
of Symptom Management.  
Organizational and Systems Leadership for Quality Improvement and Systems Thinking 
 Organizational and systems leadership is demonstrated by the ability to develop and 
evaluate care delivery with an emphasis on quality and efficiency of care provided (AACN, 
2006). The student evaluated the delivery of palliative care at an organization and identified a 
practice problem. Advanced communication and leadership skills were used to identify a 
solution to the problem. Consideration was given to budgetary concerns, the diverse populations 
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involved, and potential barriers to be faced upon implementation of the toolkit. This included an 
implementation and sustainability plan.  
Clinical Scholarship and Analytical Methods for Evidence-Based Practice 
 Scholarship and research form the foundations of doctoral education. This includes the 
ability to critically assess evidence, apply relevant evidence to practice, design and implement 
processes to evaluate practice outcomes, use information technology to collect and analyze 
outcomes, and to disseminate findings from practice and research to the healthcare community 
(AACN, 2006). The DNP student performed an integrative literature review to appraise 
evidence relevant to the phenomenon of interest and used the findings of the review to design a 
quality improvement project. The DNP student also completed a data analysis that was carried 
out using the organizational EMR. Findings were disseminated through paper publication, poster 
presentations, and an oral defense.  
Information Systems/Technology and Patient Care Technology  
 The DNP prepared nurse should also have the ability to use information systems and 
technology to transform healthcare. This includes the design, selection, and use of information 
technologies to evaluate care outcomes and financial performance (AACN, 2006).  The DNP 
student utilized the organization’s EMR to conduct a retrospective chart review. The DNP 
student also took great care to collect and store data securely. 
Health Care Policy for Advocacy in Health Care 
 Competency in healthcare policy should include the appraisal of health policies, 
leadership in the development of healthcare policies, and advocacy for the promotion of 
healthcare policies as well as for justice and equity across all healthcare settings (AACN, 2006). 
This project advocated for the availability of palliative care services to all oncology patients and 
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directly resulted in a change to the current “opt in” referral policy to an “opt out” policy. In 
addition, the DNP student participated in Nurse Practitioner advocacy day in Lansing, Michigan. 
Interprofessional Collaboration for Health Outcomes 
 Competency in interprofessional collaboration refers to communication, collaborative, 
and leadership skills to develop, implement, and sustain practice change (AACN, 2006). The 
DNP student demonstrated interprofessional collaboration through working with palliative care 
and oncology clinicians as well as administrative staff. Regular meetings were conducted as 
well as frequent e-mail and phone communication between the DNP student and all participants 
including physicians, management, nurses, and social work.  
Clinical Prevention and Population Health  
 Clinical Prevention and population health refers to the ability to analyze epidemiological, 
biostatistical, and environmental data as it pertains to individual and population health as well as 
to evaluate care delivery models in relation to diverse populations (AACN, 2006). The DNP 
student analyzed biostatistical data including primary cancer diagnosis, extent of disease, 
functional status, and patient demographics. The DNP student incorporated the psychosocial 
dimension of palliative care into this project through the application of the Theory of Symptom 
Management.  
Advanced Nursing Practice  
 Advanced nursing practice is demonstrated through the ability to perform a comprehensive 
history and physical assessment, develop an appropriate plan of care, sustain relationships with 
patients and their families, mentor other nurses, and education and guide individuals through 
health transitions (AACN, 2006). During the completion of the DNP project, the student spent 
time in both inpatient and outpatient palliative care settings seeing patients in conjunction with a 
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nurse practitioner and palliative care physician.  Additionally, assessing the clinical problem and 
designing an effective solution was made possible by the clinical knowledge gained during the 
completion of the advance practice nurse portion of the degree program. The DNP student has 
also mentored two DNP students who will be at the same project site next year.  
Dissemination of Outcomes 
 Dissemination of the evidence-based toolkit occurred through presentation to the 
stakeholders of the hospice and palliative care organization.  Project findings were also 
presented at the Three Minute Thesis Competition at Grand Valley Statue University on 
2/15/2018. The toolkit was presented at Grand Valley State University with the DNP student’s 
project team in attendance as well as other graduate nursing students and faculty. A formal 
paper detailing the scholarly project will be uploaded to ScholarWorks©. Finally, the DNP 
student will present a poster detailing the project at the organization’s student poster rounds. 
Conclusion 
 As cancer mortality decreases the number of individuals living with cancer will continue 
to grow. Oncology patients stand to greatly benefit from the early integration of palliative care. 
Unfortunately, the stakeholders of a hospice and palliative care division of a large Midwest 
healthcare system have observed that oncology patients are being referred late in their disease 
course to palliative care services, or even worse not at all. A quality improvement project 
completed by a DNP student included the development of an evidence-based toolkit to improve 
timely and appropriate referrals from oncology to palliative care.   
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Appendix A 
Barriers and Facilitators of Oncology Referrals to Palliative Care Identified in the Literature 
 
 
 
 
 
 
 
 
 
 
 
  
                              Barriers                             Facilitators  
Inadequate referring provider knowledge 
(Autor, Storey, Ziemba-Davis, 2013;  Feld, Horn, 
&Phillips ,2016;  Schenker et al ,2014). 
 
 
Belief that referral would alarm patient 
and/or families   
(Smith et al. 2012; Feld, Horn, &Phillips, 2016; Le et al 
(2014). 
 
 
Long wait times for appointments, unsure of 
locally available services 
 (Feld, Horn, &Phillips, 2016; Schenker et al , 2014)  
 
 
 
Ease of collaboration  (Le et al., 2014) 
Name change to supportive care  
(Dalal et al 2011;  Macziasz et al.,2013;  Rhondali, 
Burt, Wittenberg-Lyles, Bruera, & Dalai, 2013; 
Walbert et al.,2016). 
 
 
Ease of referral  (Le et al.2014) 
 
 
Defined communication and expectations (Le 
et al,2014) 
 
 
Patient screening/ established referral criteria 
(Rauenzhan et al.,2017;  Hui et al., 2017; Adelson et 
al., 2017) 
 
 
Provider education   
(Reville, Reifsnyder, McGuire, Kaiser, & Sanana, 
2013) 
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Appendix B 
Financial Aspects of Palliative Care: CMS 2017 Oncology Quality Measures 
 
   Measure Number  High Priority Oncology Measure 
#453 Proportion receiving chemotherapy in the 
last 14 days of life 
#454 Proportion of patients who died from cancer 
with more than one emergency department 
visit in the last 30 days of life 
#455 Proportion admitted to the ICU in the last 30 
days of life 
#456 Proportion not admitted to hospice 
#457 Proportion admitted to hospice for less than 
3 days 
#047 Care Plan: Percentage of patients who have an 
advance care plan of medical decision maker 
documented in their medical chart 
(CMS, 2017) 
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Appendix C 
 Revised Theory of Symptom Management 
 
 
 
Figure 1. Revised Symptom Management Conceptual Model. Reprinted from “ Advancing the 
Science of Symptom Management”, by Dodd., M., Facione, N., Huphreys, J., Miaskowski, C., & 
Rankin, S, 2001, Journal of Advanced Nursing, 33(5), 668-676. 
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Appendix D 
PARIHS Framework 
 
 
Figure 2. A three dimensional matrix in which evidence, context, and facilitation can either 
be expected to influence the outcome in a positive or negative way.  Reprinted from 
“Enabling the implementation of evidence based practice: A conceptual framework,” by EA. 
Kitson, G. Harvey, & B. McCormack, 1998, Quality in Health Care, 7, 149-158.  Copyright BMJ 
Publishing Group Ltd. 
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Appendix E 
The Burke-Litwin Model of Organizational Performance and Change  
 
  
Figure 3. A model of organizational performance and change. Reprinted from “A Causal Model  
 
of Organizational Performance and Change.” By W.W Burke and G.H Litwin, 1992, Journal of  
 
Management, 18(3), 528. Copyright 1992 by Southern Management Association  
 
 
Appendix F  
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SWOT Analysis of Project 
 
 
 
 
 
 
 
 
 
Appendix G 
Spread Sheet for Data Collection 
Strengths 
 
• Staff member support 
 
• Size and strength of the organization 
as a whole 
 
• CBPC clinic is already being piloted 
for Heart Failure patients  
Weaknesses 
 
• History of reluctance among oncology 
providers to refer patients to palliative 
care and hospice services.  
 
• Confusion within the organization as 
well as the healthcare system about 
the differences between palliative care 
and hospice and the programs 
currently offered 
Opportunities 
 
• MACRA legislation fostering a move 
towards performance indicators that 
are more quality, not volume focused. 
 
• Building a collaborative relationship 
with oncology providers 
Threats 
 
• Multiple competing services in the 
area that  
 
• The cost saving analysis not 
substantiating value 
 
• Oncology providers not being 
receptive  
 
• Too rapid of program growth leading 
to inadequate staffing and resources 
TOOLKIT TO IMPROVE ONCOLOGY REFERRALS TO PALLIATIVE CARE 
 
62 
  
Date Request Submitted:  Initial Draft 10/18/17  
 
Date by which this data is needed by requestor(s):  Wednesday, December 13, 2017 (pending IRB) 
 
Data Requestor(s):  Katelyn Gettel, GVSU, Doctor of Nursing Practice (DNP) student  
 
Intent:  DNP project – Examining new CMS initiatives and changes to reimbursement with Oncology 
quality measures.  Data will be summarized in aggregate (there is no intent to share individual patient 
data).   
 
Timeframe of data being requested:  A retrospective 12-month snapshot sometime in CY2017 (with the 
ability to stratify by individual month as well)  
 
Base Population Definition:  All adult Oncology patients seen/ treated at the SH United Cancer Center 
(outpatients) in Greenville, MI location with the ability to stratify by cancer diagnosis/primary site of 
cancer.   
 
 
Type of 
Metric or 
Measure 
 
Metric or Measure 
Title (column 
headings within 
the report) 
 
 
Definition 
 
Exclusion(s) 
 
Comparisons 
(National 
Best 
Practice, 
Benchmarks, 
etc.) 
Data Source 
& Format  
 
Additional 
Comments and 
Notes 
Operational 
- Volume 
Primary Cancer 
Diagnosis/Primary 
Site of Cancer 
Desire the ability 
to sort by specific 
primary cancer 
diagnosis/primary 
site of cancer 
Pediatric 
patients  
(age 0-17) 
 ICD-10-CM 
(diagnosis) 
coded data  
 
Process Total number of 
patients who 
received 
chemotherapy in 
the last 14 days 
of life (if 
deceased) 
Total number of 
patients who 
received 
chemotherapy in 
the last 14 days 
of life (if 
deceased) 
Pediatric 
patients  
(age 0-17) 
CMS Enterprise 
Data 
Warehouse 
(EDW) for 
retrospective 
data -  
CPT procedure 
code. 
Process Total number of 
patients who had 
more than one 
ED visit within the 
last 30 days (prior 
to death, if 
deceased)  
Total number of 
patients who had 
more than one 
ED visit within 
the last 30 days 
(prior to death, if 
deceased) 
Pediatric 
patients  
(age 0-17) 
CMS Enterprise 
Data 
Warehouse 
(EDW) for 
retrospective 
data - 
 
Process Total number of 
patients who had 
an ICU admission 
at any time in the 
3-month 
timeframe being 
queried 
Total number of 
patients who had 
an ICU 
admission at any 
time in the 3-
month timeframe 
being queried 
Pediatric 
patients  
(age 0-17) 
CMS Enterprise 
Data 
Warehouse 
(EDW) for 
retrospective 
data - 
 
Operational 
- Volume 
Total number of 
patients who were 
admitted to 
Hospice and LOS 
on Hospice. 
Total number of 
patients who 
were admitted to 
Hospice and LOS 
on Hospice. 
Pediatric 
patients  
(age 0-17) 
CMS Enterprise 
Data 
Warehouse 
(EDW) for 
Would like ability 
to stratify by 
which Hospice, 
Spectrum Health 
Hospice or any 
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Type of 
Metric or 
Measure 
 
Metric or Measure 
Title (column 
headings within 
the report) 
 
 
Definition 
 
Exclusion(s) 
 
Comparisons 
(National 
Best 
Practice, 
Benchmarks, 
etc.) 
Data Source 
& Format  
 
Additional 
Comments and 
Notes 
retrospective 
data - 
other area 
hospices 
Outcome or 
Operational 
– Volume  
Total number of 
patients who were 
admitted to a 
System Hospital 
Total number of 
patients who 
were admitted to 
a Delivery 
System Hospital 
Pediatric 
patients  
(age 0-17) 
 Enterprise 
Data 
Warehouse 
(EDW) for 
retrospective 
data - 
Would like ability 
to stratify by 
which SH 
Hospital  
Outcome  Total number of 
patients who have 
expired.   
Total number of 
patients who 
have expired.   
Pediatric 
patients  
(age 0-17) 
 Enterprise 
Data 
Warehouse 
(EDW) for 
retrospective 
data – SH 
Lemmen- 
Holton 
Tumor 
Registry, or 
State of 
Michigan 
Decedent 
Registry  
Would like to 
know how many 
died in the 
hospital and 
from the State of 
Michigan 
Decedent 
Registry, if 
possible. 
 
 
       
 
Additional Notes:   
 
 
 
 
 
 
 
 
 
 
 
 
Appendix H 
Literature Review of Proposed Variables 
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Source Design Sample Measurement/Data 
Analysis 
Findings Limitations CA dx Quality 
Measures 
Blechman 
et al. 
(2013) 
Retrospective 
chart review 
N=69 
Pts with 
metastatic 
CA admitted 
to ICU in 
last 2 weeks 
of life  
EOL quality indicator 
review 
22 reported having an 
advance directive (22%) 
however, only 16 were found 
on chart. 97% did not leave 
the hospital. 50 (72%) died in 
ICU, 17 (25%) of patients 
died in hospital outside ICU, 
and 2 (3%) were d/c home.  
 
Small sample 
size. No further 
characterization 
of patients 
beyond 
“metastatic 
CA”. 
 Metastatic AD, ICU 
admission. 
Earle et al. 
(2004) 
Retrospective 
claims review  
N= 28,777 
Medicare pts 
aged 65 and 
older  
Medicare Claims 
review. Multivariate 
analysis. 
Among pts receiving 
chemotherapy, 15.7% were 
still receiving tx at EOL, 
increasing from 13.8% in 
1993 to 18.5% in 1996 
(P<.001). Pts with 1> ED 
visit increased from 7.2% to 
9.2% (P<.001).  ICU 
admission w/in 30 days of 
EOL increased from 8.1% to 
9.4%,(P= .009). 
 Use of hospice increased 
(28.3% to 38.8%, P<.001). 
However, pts who rec’d 
aggressive care who entered 
hospice were more likely to 
do so w/in 3 days of death 
(35.6% v 12.1%, P<.001). 
Greater availability of hospice 
was associated with less 
aggressive treatment. No 
significant association 
between cancer type/stage 
and the aggressiveness of 
care. 
Only pts >65.  
Did not include 
all CA dx or 
differentiate 
disease stage. 
Lung (53.1-
52.8%)breast 
( 3-
3.1%)colorec
tal (34.1-
34.8%), 
GI.(9.8-
9.1%).  
From 1993-
1996. 
 
Stage at 
Presentation 
Local (9.4-
9.0%) 
Regional 
(22.8-23.2%) 
Distant 
(67.8-67.9% 
) 
Chemotherapy 
at EOL, ED 
visits w/in 30 
days EOL, 
ICU 
admission, use 
of hospice, 
LOS on 
hospice 
Green et al. 
(2016) 
Systematic 
review 
12 studies of 
ED pts, 7 
studies were 
exclusively 
CA pts. 
Empiral studies Most common CA dx 
associated with ED visits: 
Lung, bowel, breast, prostate, 
& esophageal.  
Did not specify 
what other CA 
dx were studied 
or stage of 
disease. No 
timeline from 
ED visit to 
EOL. 
Lung, 
Bowel, 
Breast, 
Prostate, 
Esophageal 
ED visits 
Henson et 
al. (2016) 
Mortality 
Follow back 
survey 
N=681 Analysis of pooled data 
from 2 mortality follow 
back surveys 
29.7% experienced 2 or more 
ED visits, 17.1% spent > 30 
days in the hospital, & 37.9% 
died hospitalized. Pts w/ 
prostate or hematologic were 
more likely to experience 
aggressive care (adjusted OR 
4.36, 95% CI 1.39-13.70 and 
4.16, 95% CI 1.38-12.47).  
Patients who had >5 GP 
visits, community nursing, or 
contact with CBPC were less 
likely to experience 
aggressive EOL care (AOR 
0.27, 95% CI 0.15-0.49).  
Inherent 
limitations of 
follow-back 
design 
Prostate & 
Hematologic
.  
Aggressive 
EOL care 
Defined as: 2 
or more ED 
visits in last 
30 days of 
life, Greater 
than or equal 
to 30 days in 
the hospital, 
or death in the 
hospital. 
Mathew et 
al. (2017) 
Retrospective 
cohort 
N=274 pts 
with 
metastatic 
breast CA tx 
at university 
CA Center 
deceased 
between 
2010-2012 
Chart review, Chi 
Sqaure, Fisher’s exact 
test, Wilcoxon ranks. 
Multivariate logistic 
regression 
28 (10.2%) rec’d 
chemotherapy w/in 2 wks 
EOL& 62. (22.6%) rec’d 
chemotherapy w/in 4 wks 
EOL. No difference in 
baseline characteristics of 
disease (histology, HR status, 
HER2 status, CNS disease). 
However, younger age at 
metastatic dx and increasing 
No account of 
functional 
status or QOL 
Metastatic 
Breast CA 
Chemotherapy 
within 2 or 4 
weeks of 
death. 
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number of organ systems 
involved were predictors of 
both 2 and 4 wk 
chemotherapy use (age odds 
ratio 0.94-0.99 & number of 
organ systems 1.16-1.87). 
 
Nappa et al 
(2011) 
Control trial 80 incurable 
epithelial CA 
pts, 160 
control 
80 incurable epithelial 
cancer patients who 
used the performance 
Status in palliative 
chemotherapy 
questionnaire (PSPC) 
before palliative 
chemotherapy (PCT) 
were compared to 160 
controls across 4 cancer 
centers in Sweden using 
Chi square and non-
parametric Whitney- U 
test. 
No significant difference 
between PSPC and control in 
terms of proportion receiving 
PCT in last month of life. 
Absolute proportion of 
patients receiving PCT during 
last month of life was 25% 
(PSCP 23.8%, control 26.3%, 
p=0.68). 
Most common cancers were 
colon 23 PSCP 25 control 
(28.8%,28.1%), Breast 14  
PSCP 27 control(17.5%, 
16.9%), Upper GI 20 PSCP 
41 control (25%, 25.6%)., 
Urologic 9 USPC 17 control 
(11.3%, 10.6%), Lung 3 
PSCP 8 control (3.8%, 5%).  
Performance status was 
documented for 48% of 
patients with no statistical 
difference between groups. 
 
Poor 
documentation 
of functional 
status,  
mismatch in 
control vs 
interventional 
groups size. 
Colon, 
Breast, 
Upper GI, 
Urologic, 
Lung,  
Chemotherapy 
within 30 days 
EOL 
Pacetti et 
al. (2015) 
Retrospective 
chart review 
N=2164 with 
advanced 
CA who 
rec’d 
chemotherap
y from 2010-
2012  
Descriptive statistic 
analysis 
162 (24.3%) received 
chemotherapy within 30 days 
EOL.  Median ECOG status 
2. All with metastatic dx.  
Lung CA 49(30.3%), G.I 
31(19/2%), Pancreatic 25 
(15.4%), ORL 14( (8.6%). 
Excluded 
hematologic 
malignancies, 
small sample 
size 
Metastatic 
Lung, GI, 
Pancreatic, 
ORL  
Chemotherapy 
within 30 days 
EOL. 
Stuver et al 
(2016) 
Retrospective 
cohort 
N= 674 
Pts who died 
from 7/2010-
12/2012 
insured by 
BCBS of  
MA 
Claim data. 
Chi square 
Overall 14.7% > 1 ED visit 
in 30 days EOL, 15.4%  had 
ICU admission w/in 30 days 
EOL, 12.2% expired in ICU, 
10.4% received 
chemotherapy w/in 14 days 
EOL , 59.9% admitted to 
hospice, 13.6% admitted to 
hospice for <3 days for a 
median stay of 14 days. 
Hematologic malignancies 
were associated w/ ICU 
admission, chemotherapy 
w/in 14 days EOL, more 
likely to die in the ICU, & 
less likely to be enrolled in 
hospice (P<.001). 
Gynecologic CA were more 
likely to experience >1 ED 
visit w/in 30 days EOL 
(P<.04). 
 
Potential 
inaccuracy of 
claims data 
Breast, GI, 
GU, 
Gynecologic, 
head/neck 
Hematologic
, Thoracic 
ED visit 30 
days EOL, 
ICU 
admission 30 
days EOL, 
Chemotherapy 
14 days EOL, 
Hospice 
admission, 
Hospice LOS, 
Death in ICU 
 
 
 
 
Appendix I 
 Eastern Cooperative Oncology Cooperative (ECOG) Tool 
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Toxicity and response criteria of the Eastern Cooperative Oncology Group.  Reprinted from 
“ Toxicity and Response Criteria of the Eastern Cooperative Oncology Group”. By Oken, 
M.M., Creech, R.j., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., & Carbone, P.P, 1982, 
American Journal of Clinical Oncology, 5, 649-655. Copyright The Eastern Cooperative 
Oncology Group, Robert Comis, M.D., Group Chair 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix J 
Variables Analyzed 
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Dependent Variables                         Measurement 
 
1. > 1 Emergency Room visits within 30 days of death                     Y/N 
2. ICU admission within 30 days of death                     Y/N 
3. Advance Directive Completion Status      Y/N 
4. Expire without admission to hospice                                Y/N 
5. Hospice LOS <3 days                                                            Y/N 
6. Chemotherapy within 14 days of death                                                  Y/N 
Independent Variables  
Breast 
Lung/Bronchus 
Prostate 
Colon/Rectum/Esophageal 
Renal/Bladder 
Hematologic 
Gynecologic 
Pancreas 
Gender 
Age 
Metastasis (defined as spread beyond initial organ system and local lymph nodes) 
Receipt of Palliative care services (as inpatient or outpatient) 
ECOG score (0-4)  
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Appendix K 
 Budget for Project 
 
Table 1 Budget for Project  
Personnel or Item Hourly Wage X Projected 
Time 
Cost of Item 
Chief of Department 1,200  
Manager of Program 
Development 
400  
APRN 450  
DNP Student 8,400  
Laptop  1200 
Total 6350 1200 
Net 5,150  
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Appendix L 
Timeline for Steps of Program Development 
 
 
Chart review/          Referral criteria                          Marketing/educational     Present toolkit to   Upload to  
data collection     based on regression analysis     for referring providers     stakeholders         3/6/18 
1/26/18      2/23/18                             2/23/18                            3/9/2018            Scholarworks©                                                                         
 
             
 
    Cost savings analysis          Protocol for implementing               Sustainability plan        Defend final toolkit 
    2/23/18        toolkit   2/23/18                    2/23/18  3/9/18 
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Appendix M 
  Organization Letter of Support  
 
 To whom it may concern, 
This letter is to verify that GVSU DNP student, Katelyn Gettel is completing her 
scholarly project entitled “Toolkit to Improve Oncology Referrals to Palliative Care” 
at Spectrum Health Hospice and Palliative Care. She will be working with Dr. Simin 
Beg as her organizational mentor. The project will be complete in April of 2018. 
We appreciate the opportunity to host a DNP student and will provide Kate with the 
information and resources that she needs to complete her project. 
Sincerely, 
 
Angela Kinch, RN, BSN 
Manager of Business and Program Development 
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Appendix N  
Quality Measure Performance  
 
Table 2 MIPS Scorecard 
 
Table 3 Current Performance with Assigned Points 
Sample  
Size  
Measure 
Number 
High Priority Oncology  
Measure 
Current           
Status 
Target Estimated 
Points 
45 453 Proportion of patients  
who received chemotherapy in  
last 14 days of life 
  8.89% *Estimated 
<*20% 
10 
45 454 Proportion of patients who died 
from CA with >1 ED visit within 
last 30 days of life. 
  11.11% *Estimated 
<10% 
8.89 
45 455 Proportion of patients admitted to 
ICU in last 30 days of life 
  11.11% *Estimated 
<10% 
8.89 
45 456 Proportion not admitted to hospice 
 
  33.33% *Estimated 
<20% 
6.67 
45 457 Proportion admitted to hospice for 
less than 3 days 
  33.33% *Estimated 
<20% 
6.67 
160 047 Proportion without Advance 
Directive in chart 
  61.88% *Estimated 
<20% 
3.82 
 
*percentiles for these quality measures are not yet established  
 
 
 
 
 
 
 
Category Weight Possible 
Points 
Estimated 
Points 
Possible 
Score 
Estimated 
Weighted 
Score 
 Quality 60% 60 44.94 60 44.94 
Improvement 
Activities 
15% 40 40 15 15 
Advancing Care 
Information 
25% 100 100 25 25 
TOTAL 100% 200 184.94 100 84.94 
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Appendix O 
Cost Saving Analysis 
Table 4 Payment Adjustment Key 
 
 
 
 
 
 
 
Table 5 Estimated Cost Adjustments Based on Performance 
Cost of Service Adjustment 
2019 
+/- 4% 
Adjustment X 
Current 
performance 
2019 (5 patients) 
Adjustment 
2022 
+/- 9% 
Adjustment X 
current 
Performance 
2022 (5 patients) 
ED visit 
$1,000  
$40.00 $200.00 $90.00 $450.00 
ICU Admission 
$2,130/day 
$85.20 $426.00 $191.70 $958.50 
 
 
 
 
 
  
Final Score Payment Adjustment Estimated 
Payment 
Adjustment 
Additional performance 
threshold >70 points    
• Positive Adjustment 
• Eligible for additional adjustment for 
exceptional performance bonus 
100 
4-69 points • Positive Adjustment 
• Not eligible for additional adjustment 
for exceptional performance bonus 
75 
Performance 
threshold= 3 points 
• Neutral Adjustment 25 
O Points • Negative payment adjustment of -4% 
• 0 points- does not participate 
0 
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Appendix P  
Description of Total and Deceased Population 
 
Table 6a Total Population Age (N=160)  Table 6b Deceased Population Age (n=45) 
 
 
 
Table 7a Gender of Total Population (N=160)   Table 7b Gender of Deceased Population (n=45) 
  
   
Table 8a Primary Cancer Total Population (N=160) Table 8b Primary Cancer Deceased (n=45) 
 
 
Table 9a Metastasis Total Population (N=160)            Table 9b Metastasis Deceased (n=45) 
 
 
 
 
 N Mean Standard 
Deviation 
Age 160 67.43 11.36 
 N Mean Standard 
Deviation 
Age 45 68.09 13.08 
Gender Frequency Percent 
Male 59 36.88% 
Female 101 63.13% 
Gender Frequency Percent 
Male 25 55.56% 
Female 20 44.44% 
Primary Frequency Percent 
Bladder 2 4.44% 
Breast 3 6.67% 
Cholangiocarcinoma 1 2.22% 
Colon 7 15.56% 
Esophageal 4 8.89% 
Gynecologic 2 4.44% 
Hematologic 3 6.67% 
Liver 1 2.22% 
Lung 15 33.33% 
Pancreatic 4 8.89% 
Prostate 3 6.67% 
Primary Frequency Percent 
Bladder 3 1.88% 
Breast 52 32.50% 
Cholangiocarcinoma 1 0.63% 
Colon 19 11.88% 
Esophageal 4 2.50% 
Gynecologic 6 3.75% 
Hematologic 22 13.75% 
Liver 3 1.88% 
Lung 33 20.63% 
Pancreatic 3 1.88% 
Prostate 6 3.75% 
Rectal 4 2.50% 
Renal 4 2.50% 
Metastatic Frequency Percent 
No 9 6.82% 
Yes 41 93.18% 
Frequency Missing = 1 
Metastatic Frequency Percent 
No 94 58.75% 
Yes 66 41.25% 
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Appendix P  
Description of Total and Deceased Population 
 
Table 10a ECOG Total Population (N=160)          Table 10b ECOG Deceased (n=45) 
ECOG Frequency Percent 
0 91 56.88% 
1 51 31.88% 
2 11 6.88% 
3 7 4.38% 
 
Table 11a Palliative Care Total (N=160)              Table 11b Palliative Care Deceased (n=45) 
     
PC Frequency Percent 
No 150 93.75% 
Yes 10 6.25% 
 
  
ECOG Frequency Percent 
1 6 13.33% 
2 23 51.11% 
3 10 22.22% 
4 6 13.33% 
PC Frequency Percent 
  No 25 55.56% 
Yes 20 44.44% 
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Appendix Q 
Recommendations for Referring Oncology Providers  
 
All patients with a life limiting illness should be considered for referral to palliative care 
services. Particularly those patients who: 
• Have advanced disease (metastasis) or locally aggressive disease 
• Have failed first line therapy 
• Have a low functional status ECOG ≥ 2 
• Have a need for goals of care discussion or advance care planning 
• Have had multiple ED or inpatient admissions for uncontrolled symptoms 
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Appendix R 
Predictors of Quality Measure Performance 
Table 12 Deceased Patients Predictors of Outcome Performance (n=45) 
 
 
 
 
 
 
 
 
 
 
Table 13 Two Sample t-test Deceased Patients Age as Predictor of Outcome Performance(n=45) 
 
 
 
Table 14 Logistic Regression Predictors of Advance Directive in Total Population (N=160) 
 
 
  
 
Table 15 Two Sample t-test Predictor of Advance Directive using Age Total Population (N=160) 
 
 
Independent Dependent P-value Test Significant 
Gender AD 0.9465 Chi-Square No 
ED 0.3577 Fisher’s No 
ICU 0.2799 Fisher’s No 
Hospice 0.6714 Chi-Square No 
Hospice LOS < 3 days 0.0222 Fisher’s Yes 
Chemo w/in 14 days of death 0.1913 Fisher’s No 
Metastatic AD 0.3443 Fisher’s No 
ED 0.7460 Fisher’s No 
ICU 0.6900 Fisher’s No 
Hospice 0.2299 Fisher’s No 
Hospice LOS < 3 days 0.2209 Fisher’s No 
Chemo w/in 14 days of death 0.7460 Fisher’s No 
PC AD 0.0189 Chi-Square Yes 
ED 0.3577 Fisher’s No 
ICU 0.0435 Fisher’s Yes 
Hospice 0.0897 Chi-Square No 
Hospice LOS < 3 days 0.0823 Fisher’s No 
Chemo w/in 14 days of 
death 
0.3087 Fisher’s No 
Independent Dependent P-
value 
Significant? 
Age AD 0.7906 No 
Predictor P-value Significant? 
Gender 0.6144 No 
Primary 0.9873 No 
Metastatic 0.7008 No 
ECOG 0.5690 No 
Predictor P-value 
Age 0.0033 
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Appendix S 
Implementation of Toolkit Utilizing PARIHS Framework 
Table 16 
  
Concept Action Time  
Evidence   
Research Literature review summarizing benefits of incorporating palliative care 
into oncology care, facilitators and barriers to integration of palliative 
care in to standard oncology care, and grey literature regarding 
upcoming reimbursement changes. 
10/2017 
Clinical 
experience 
Organizational Assessment included review of referral statistics and 
interviewing administrative and clinical palliative care staff members 
and demonstrated low number of oncology referrals to palliative care.  
9/2017 
Local 
information 
A retrospective chart review was completed revealing data about current 
oncology quality measures in need of improvement. 
1/2018 
Context   
Culture Define current values: Providing the best care possible to patients with 
life limiting illnesses. Resources allocated to growth and development 
was established in organizational assessment (Currently hiring 
physicians and RNs, new care choices and CBPC program).  
9/2017 
Leadership Vertical chain of command is well established. Both medical director, 
manager of practice development, and administrative VP are devoted to 
organizational values as established in organizational assessment. 
 
Current DNP student will service as “champion” for the toolkit followed 
by another DNP student. Strong support for DNP students within the 
organization. 
9/2017 
 
 
 
 
5/2018 
Evaluation Success of current project will be measured by acceptance of toolkit. 
 
Implementation of toolkit success will be measured by comparing pre 
and post oncology referral statistics and quality measure performance 
2/2018 
 
 
1/2019 
Facilitation   
Purpose The purpose of this toolkit is to promote incorporating evidence based 
standards into practice (incorporation of PC into standard oncology 
care). It will be important that this is emphasized in presentation to 
stakeholders and in communicating with referring providers. 
2/2018-
ongoing 
Roles APPs and physicians need to provide evidence based palliative care that 
promotes patient autonomy and ultimately high quality measure 
performance. This will need to be established during presentation to 
stakeholders and reinforced periodically.  
Palliative care staff members should also be encouraged to foster 
professional relationships with referring oncology providers, as ease of 
collaboration was an identified barrier in the literature.  
2/2018-
ongoing 
Skills/ 
Attributes 
Marketing Skills: Marketing tools will be produced and distributed. 
Giving Meaning: Reinforcing the value in both cost savings and quality 
performance. Disseminating results of implementation. 
2/2018 
2/2018-
ongoing 
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Appendix T  
Steps for Implementation of Toolkit 
 
1.  Present toolkit to organizational stakeholders on 2/16/2018 
2. Present toolkit to palliative care clinicians on 2/22/2018 
3. Await permission from hospice and palliative care manger of practice and development to 
disseminate marketing/educational materials to referring providers. Note, this will likely be after 
the new EMR regional go- live (April-May of 2018) and after the posted FTEs for new 
physicians and nurses have been filled 
4. Disseminate marketing and educational tools to referring providers at downtown campus 
estimated 9/2018 
5. Change champion (either volunteer clinician or next DNP student) participate in rounds at 
hospital with palliative care team to monitor for any questions or feedback using palliative care 
staff feed back form 
6. Collect post implementation data 12/2018 utilizing referral tracking table and quality measure 
performance tracking table 
7. Evaluate post implementation data. If there is improvement in number of oncology referrals 
proceed to step 8. If no improvement in referrals, proceed with evaluation of referring providers’ 
response to the materials using referring provider feedback form, modify as necessary and return 
to step 4 
8. Disseminate marketing and educational tools to referring providers at regional campuses with 
access to palliative care services 
9. Repeat steps 5-7. 
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Appendix U 
Marketing and Educational Material  
 
 
 
 
 
 
 
 
 
 
 
Considering palliative and supportive care? 
 
 
 
In an analysis of 45 deceased patients treated at ******** patient age, primary cancer diagnosis, 
extent of disease, and functional status were not associated with quality measure performance. 
 
Palliative and Supportive Care 
 
Was significantly associated with advance directive completion (60% vs 40%, p=.0189) 
 
Was significantly associated with lower ICU utilization in last 30 days of life (0% vs 100%, 
p=.0435)* 
* limited by small sample size 
Comprehensive Medicare and Medicaid Reimbursement Changes coming in 2019 focus on quality measure 
performance.  There are 6 new high priority oncology diagnoses related to end of life care. 
 
• Proportion of patients with a completed Advance Directive  
• Proportion of patients admitted to hospice for less than three days 
• Proportion of patients admitted to intensive care in the last 30 days of life 
• Proportion of patients who died from cancer without being admitted to hospice 
• Proportion of patients who received chemotherapy within 14 days of death  
• Proportion of patients who died from cancer with more than one emergency department visit in the last 
30 days of life (CMS, 2017).  
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Appendix V 
Palliative Care Staff Member Feedback Form 
 
1.  The marketing and educational materials have led to increased awareness about palliative care 
referrals among oncology providers. 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
2. I feel comfortable giving the materials to referring providers who have not already received 
them. 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
3. I feel comfortable discussing or answering questions about the materials with referring 
providers. 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
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Appendix W  
Referring Provider Feedback Form 
 
1.  The marketing and educational materials have increased my awareness about what value 
palliative care can bring to my practice 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
2. The marketing and educational tools have improved my ability to talk with my patients about 
a palliative care referral. 
Strongly disagree    Disagree         Neutral        Agree        Strongly agree     
3. I believe that incorporating palliative care may improve my end of life quality measure 
performance 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
4. The materials have led me to change my referral practices 
Strongly disagree     Disagree        Neutral       Agree        Strongly agree  
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Appendix X 
Evaluation Tools for After Toolkit Implementation 
 
Table 17 Referral Data Tracking Sheet 
 
 
 
 
 
 
 
 
Table 18 Quality Measure Performance Tracking Sheet 
 
 
 
MRN Age Gender Diagnosis  Care Level LOS at time 
of Consult 
      
MRN Primary 
CA 
PC AD Deceased? ED within 30 
days of death 
ICU w/in 
30 days 
of death 
Hospice Hospice 
LOS  <3 
days 
Chemo w/in 
14 days of 
death 
          
